(Q66899031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Methotrexate, cyclophosphamide and vincristine (MEV regimen) for non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference

F. Lauria

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1098915

21 August 2022

M. Baccarani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1098915

21 August 2022

M. Fiacchini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1098915

21 August 2022

M. Gobbi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1098915

21 August 2022

S. Tura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1098915

21 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1098915

21 August 2022

publication date

1 May 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.elsevier.com/content/article/PII:0014296475900626?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

https://api.elsevier.com/content/article/PII:0014296475900626?httpAccept=text/plain

19 September 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

European Journal of Cancer

19 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

343-349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

cites work

The therapy of lymphoma

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Treatment of the lymphomas

19 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

A decade of combination chemotherapy of advanced Hodgkin's disease

19 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

19 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma

19 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma

19 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Combination sequential chemotherapy in advanced reticulum cell sarcoma

19 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Combination chemotherapy for spontaneous AKR lymphoma

19 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Combination Chemotherapy with Methotrexate, Endoxan, and Vincristine (M.E.V.) in the Treatment of non-Hodgkin's Lymphoma

19 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Report of the Committee on Hodgkin's Disease Staging Classification

19 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

19 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomas

19 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Non-Hodgkin's lymphomas.I. Bone marrow involvement

19 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

A critique of the value of laparotomy and splenectomy in the evaluation of patients with Hodgkin's disease

19 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas

19 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Herpes Zoster-Varicella infections and lymphoma

19 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

Primary management of advanced lymphosarcoma with radiotherapy

19 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90062-6

19 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1098915%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference